Literature DB >> 14738761

Dendritic cells: immunobiology and cancer immunotherapy.

Carlos Ardavín1, Sebastián Amigorena, Caetano Reis e Sousa.   

Abstract

A recent workshop on "Dendritic Cells: Biology and Therapeutic Applications," sponsored by the Juan March Foundation, brought together basic and clinical research scientists to discuss the mechanisms underlying the control of immune responses and tolerance by dendritic cells (DCs), as well as recent research in cancer immunotherapy based on DC vaccination. Particular emphasis was placed on antigen processing and presentation by DCs, C-type lectin antigen receptors, DC maturation and polarization of T cell responses, the control of immunity versus tolerance by DCs, the developmental origin of DCs, and the use of DCs in cancer immunotherapy.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14738761     DOI： 10.1016/s1074-7613(03)00352-2

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  36 in total

1.  Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

Authors:  Elina I Zuniga; Dorian B McGavern; Jose L Pruneda-Paz; Chao Teng; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

Review 2.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

4.  Lentiviral calnexin-modified dendritic cells promote expansion of high-avidity effector T cells with central memory phenotype.

Authors:  Bei Wang; Shuhong Han; Lily Lien; Lung-Ji Chang
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

Review 5.  Emerging roles for myeloid immune cells in bone metastasis.

Authors:  Massar Alsamraae; Leah M Cook
Journal:  Cancer Metastasis Rev       Date:  2021-04-14       Impact factor: 9.264

6.  Immune dysregulation by the rheumatoid arthritis shared epitope.

Authors:  Denise E De Almeida; Song Ling; Xiujun Pi; Anne M Hartmann-Scruggs; Paul Pumpens; Joseph Holoshitz
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

7.  Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Authors:  Juan C Salazar; Constance D Pope; Meagan W Moore; Jonathan Pope; Thomas G Kiely; Justin D Radolf
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 8.  Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation.

Authors:  Rosanna Ramhorst; Esteban Grasso; Daniel Paparini; Vanesa Hauk; Lucila Gallino; Guillermina Calo; Daiana Vota; Claudia Pérez Leirós
Journal:  Cell Adh Migr       Date:  2016-02-18       Impact factor: 3.405

9.  Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12.

Authors:  Ana Ceballos; Juan Sabatté; Karen Nahmod; Diego Martínez; Gabriela Salamone; Mónica Vermeulen; Julián Maggini; Horacio Salomón; Jorge Geffner
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

10.  Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.

Authors:  Tai-Gyu Kim; Chang-Hyun Kim; Jung-Sun Park; Sung-Dong Park; Chung Kwon Kim; Dong-Sup Chung; Yong-Kil Hong
Journal:  Clin Vaccine Immunol       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.